Literature DB >> 10199110

Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models.

C B Denney1, M D Rapport.   

Abstract

OBJECTIVE: To evaluate the theoretical merit and empirical validity of models designed to predict response to methylphenidate (MPH) among children with attention-deficit/hyperactivity disorder (ADHD).
METHOD: Seventy-six children with ADHD received each of 4 counterbalanced doses of MPH (5, 10, 15, and 20 mg) in the context of a double-blind, placebo-controlled, within-subject (crossover) experimental design. Logical and conceptual foundations of 3 models of MPH response were subjected to critical scrutiny, and patterns of relationship anticipated on the basis of these models were subjected to empirical analysis.
RESULTS: The conceptual foundations of all reviewed models were found to be substantially flawed, and none provided an adequate empirical basis for predicting response to MPH among children with ADHD.
CONCLUSIONS: The observed pattern of relationships suggests that magnitudes of response to MPH in domains of classroom attention and behavioral disinhibition are correlated and differentially predictive of response on measures of academic performance and teacher-rated behavior.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199110     DOI: 10.1097/00004583-199904000-00011

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  7 in total

1.  Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Heather M Conklin; Susan Helton; Jason Ashford; Raymond K Mulhern; Wilburn E Reddick; Ronald Brown; Melanie Bonner; Bruce W Jasper; Shengjie Wu; Xiaoping Xiong; Raja B Khan
Journal:  J Pediatr Psychol       Date:  2009-05-22

2.  Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.

Authors:  Chris Bushe; Esther Sobanski; David Coghill; Lovisa Berggren; Katrien De Bruyckere; Sami Leppämäki
Journal:  CNS Drugs       Date:  2016-04       Impact factor: 5.749

3.  Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report.

Authors:  Margaret A Sheridan; Stephen Hinshaw; Mark D'Esposito
Journal:  J Atten Disord       Date:  2010-07       Impact factor: 3.256

4.  Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.

Authors:  Mark A Stein; Irwin Waldman; Jeffrey Newcorn; Jeffrey Bishop; Rick Kittles; Edwin H Cook
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

5.  Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome.

Authors:  Saskia van der Oord; P J M Prins; J Oosterlaan; P M G Emmelkamp
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

Review 6.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

7.  Clinical and Neuropsychological Predictors of Methylphenidate Response in Children and Adolescents with ADHD: A Naturalistic Follow-up Study in a Spanish Sample.

Authors:  María Vallejo-Valdivielso; Pilar de Castro-Manglano; Azucena Díez-Suárez; Juan J Marín-Méndez; Cesar A Soutullo
Journal:  Clin Pract Epidemiol Ment Health       Date:  2019-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.